Stay updated on Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial
Sign up to get notified when there's something new on the Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial page.

Latest updates to the Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated from version v2.16.1 to v2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check76 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about the clinical trial for Letetresgene autoleucel (GSK3377794) and its associated criteria, while adding a new identifier related to Adaptimmune Therapeutics.SummaryDifference12%
- Check84 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial page.